U.S. Clinical Laboratory Tests Market Size Worth USD 95.24 Billion by 2034 | CAGR: 6.1%

The U.S. clinical laboratory tests market size is expected to reach USD 95.24 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Clinical Laboratory Tests Market Share, Size, Trends, Industry Analysis Report: By Type (Blood Count, HGB/HCT, Basic Metabolic Panel), By End Use; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Clinical laboratory tests are defined as critical diagnostic evaluations that aid physicians in detecting, monitoring, and managing a wide range of health conditions. The U.S. clinical laboratory tests market is driven by the integration of advanced diagnostic technologies, which have enhanced the precision, speed, and accessibility of testing services. Innovations such as molecular assays, next-generation sequencing, and automation have transformed traditional laboratory workflows, enabling faster turnaround times and more reliable results. This trend has boosted the role of laboratory testing from routine diagnostics to an essential tool for early disease detection and comprehensive patient management, reinforcing its importance in improving overall healthcare outcomes.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/us-clinical-laboratory-tests-market/request-for-sample

The U.S. clinical laboratory tests market is driven by the rising focus on personalized medicine, which requires advanced diagnostics tailored to individual patient profiles. Laboratory testing has a central role in identifying biomarkers, genetic predispositions, and treatment responses, thereby supporting targeted therapies. The growing adoption of precision healthcare is fueling demand for specialized and vast tests that go beyond routine diagnostics. This shift towards patient-centric solutions is reinforcing the strategic importance of laboratory services in delivering effective, customized medical care.

Top of FormU.S. Clinical Laboratory Tests Market Report Highlights

• In terms of type, the HbA1c segment held a 16.42% revenue share in 2024, driven by growing diabetes rates and an increased focus on long-term blood sugar management.
• Based on end use, the primary clinics segment is projected to grow at an 8.7% CAGR, fueled by the shift toward decentralized care and improved local diagnostic access.
• A few global key market players include Abbott Laboratories; ARUP Laboratories; BioReference Laboratories, Inc.; Charles River Laboratories; Genoptix, Inc.; LabCorp; Mayo Clinic Laboratories; NeoGenomics Laboratories, Inc.; OPKO Health, Inc.; and Quest Diagnostics.

Polaris Market Research has segmented the market report on the basis of type, end use:

By Type Outlook (Revenue, USD Billion, 2020–2034)

• Complete Blood Count
• HGB/HCT
• Basic Metabolic Panel
• BUN Creatinine Tests
• Electrolytes Testing
• HbA1c Tests
• Comprehensive Metabolic Panel
• Liver Panel
• Renal Panel
• Lipid Panel

By End Use Outlook (Revenue, USD Billion, 2020–2034)

• Central Laboratories
• Primary Clinics